Yes I am still holding. And I do think they are doing good.
They are consistently moving forward even though it has been at a much slower pace than I expected. There was also a lot still to be done, but now that cGMP seems to be around the corner with an IND approval, I am extremely excited about getting into human trials.
It's still risky for sure... R&D biotech with no revenue... But I see no reason to change my course...
News 
Market Data 
Discover 
AI
